Need Physician Approval
LORBRENA 100mg 30TABS.
19,267.10
In stock
SKU :
103823
Targeted ALK+ lung cancer therapy
Product Description
Lorbrena (lorlatinib) 100mg Tablets (30 pcs) are prescribed to treat ALK-positive metastatic non-small cell lung cancer (NSCLC). It targets cancer cell growth to slow disease progression and improve survival.
Key Benefits
- Treats ALK-positive NSCLC
- Slows disease progression
- Improves patient survival
- Oral once-daily tablet
| Offer Label | Need Physician Approval |
|---|---|
| Shipping Type | Express |
Write Your Own Review
